The Food and Drug Administration yesterday revised its April 3 emergency use authorization for N95 and similar respirators made in China to remove certain respirators that failed to demonstrate at least 95% particulate filtration efficiency when tested by the National Institute for Occupational Safety and Health. Health care personnel should not use these respirators as personal protective equipment but may use them as face masks, FDA said. The unauthorized models are made by: CTT Co. Ltd; Daddybaby Co. Ltd; Dongguan Xianda Medical Equipment Co. Ltd.; Guangdong Fei Fan Mstar Technology LTD; Guangdong Nuokang Medical Technology Co. Ltd.; Huizhou Huinuo Technology Co. Ltd.; and Lanshan Shendun Technology Co.

Related News Articles

Perspective
For the last few weeks, we’ve used this space to highlight the need for the next COVID-19 relief package to provide hospitals and health systems with…
Headline
President Biden yesterday continued the national emergency for the COVID-19 pandemic beyond March 1. The renewed national emergency, along with the recently…
Headline
The AHA and eight other hospital organizations today urged Senate leaders to include additional COVID-19 relief funding for health care providers in the…
Headline
The Food and Drug Administration's Office of Minority Health and Health Equity today released two videos on COVID-19 vaccines and the importance of communities…
Headline
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines,…
Headline
President Biden today will sign an executive order to create more resilient and secure supply chains for critical and essential goods, the White House…